These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32722374)

  • 21. Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study.
    Ilo D; Raluy-Callado M; Graham-Clarke P; Sadasivan R; Birt J; Donaldson R; Zhu E; Kirby MG; Neasham D
    Int J Clin Pract; 2015 Aug; 69(8):853-62. PubMed ID: 26011100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction factors of recurrent ischemic events in one year after minor stroke.
    Zhang C; Zhao X; Wang C; Liu L; Ding Y; Akbary F; Pu Y; Zou X; Du W; Jing J; Pan Y; Wong KS; Wang Y; Wang Y;
    PLoS One; 2015; 10(3):e0120105. PubMed ID: 25774939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benign neoplasm of the heart increases the risk of first ischemic stroke: a population-based cohort study.
    Lai MM; Li TC; Lin CL; Sung FC; Lin CC; Liu CS; Kao CH
    Int J Stroke; 2015 Feb; 10(2):202-6. PubMed ID: 25055877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.
    Logan YT; Belgeri MT
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):103-14. PubMed ID: 16129387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia.
    Souverein PC; Herings RM; Man in 't Veld AJ; de la Rosette JJ; Farmer RD; Leufkens HG
    Eur Urol; 2002 Sep; 42(3):254-61. PubMed ID: 12234510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benign prostatic hyperplasia and cardiovascular risk: a prospective study among Chinese men.
    Wang X; Su Y; Yang C; Hu Y; Dong JY
    World J Urol; 2022 Jan; 40(1):177-183. PubMed ID: 34426873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
    Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
    Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Approaches to medical management of patients with high risk of progressing of benign prostatic hyperplasia depending on concomitant erectile dysfunction].
    Kamalov AA; Takhirzade AM
    Urologiia; 2018 Jul; (3):70-77. PubMed ID: 30035422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemic stroke history predicts increased cardiovascular mortality in chronic heart failure.
    Kozdağ G; Yaymacı M; Işeri P; Ertaş G; Emre E; Bildirici U; Kılıç T; Ural D
    Anadolu Kardiyol Derg; 2011 Aug; 11(5):421-7. PubMed ID: 21712170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Wang H; Ning X; Zhu C; Yin D; Feng L; Xu B; Guan C; Dou K
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):787-792. PubMed ID: 30618111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke severity may predict causes of readmission within one year in patients with first ischemic stroke event.
    Hsieh CY; Lin HJ; Hu YH; Sung SF
    J Neurol Sci; 2017 Jan; 372():21-27. PubMed ID: 28017214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular Safety and Possible Benefit of a 5-Alpha Reductase Inhibitor among Benign Prostatic Hyperplasia Patients, A Nationally Representative Cohort of Korean Men.
    Chang J; Choi S; Kim K; Park SM
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31121994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms/benign prostatic hyperplasia.
    Yoshida M; Inadome A; Masunaga K; Nagata T; Yoshiyasu T
    Neurourol Urodyn; 2010 Sep; 29(7):1276-81. PubMed ID: 20878997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
    Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lifestyles correlate with stroke recurrence in Chinese inpatients with first-ever acute ischemic stroke.
    Huang ZX; Lin XL; Lu HK; Liang XY; Fan LJ; Liu XT
    J Neurol; 2019 May; 266(5):1194-1202. PubMed ID: 30847644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-Ever Ischemic Stroke and Incident Major Adverse Cardiovascular Events in 93 627 Older Women and Men.
    Sposato LA; Lam M; Allen B; Shariff SZ; Saposnik G;
    Stroke; 2020 Feb; 51(2):387-394. PubMed ID: 31914883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-Blocker and Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Nationwide Population Based Study Using the National Health Insurance Service Database.
    Tae BS; Jeon BJ; Choi H; Cheon J; Park JY; Bae JH
    J Urol; 2019 Aug; 202(2):362-368. PubMed ID: 30840545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study.
    Huang WS; Tseng CH; Chen PC; Tsai CH; Lin CL; Sung FC; Kao CH
    Eur J Intern Med; 2014 Jul; 25(6):561-5. PubMed ID: 24906568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive white matter changes predict stroke recurrence up to 5 years after a first-ever ischemic stroke.
    Melkas S; Sibolt G; Oksala NK; Putaala J; Pohjasvaara T; Kaste M; Karhunen PJ; Erkinjuntti T
    Cerebrovasc Dis; 2012; 34(3):191-8. PubMed ID: 23006549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.